The PERMIT project aims to build recommendations for robust and reproducible personalised medicine research. A first stage of the project focuses on performing a review of existing literature to map existing methodologies and identify gaps and opportunities for recommendations. The protocol for this scoping review project has been made publicly available, and now an abstract of this methodology has been published in a special issue of the Cochrane Library, entitled Advances in Evidence Synthesis. This abstract was submitted by the PERMIT project for the Cochrane Colloquium 2020, but due to the COVID-19 pandemic this event was postponed until September 2022. The abstract was nevertheless selected by the organizers to be part of this special edition and can be found online (p403).
🗣️On the age#patienttient auton#HTA #HTA, acces#PMo #PM, in-depth discussion w/ participants The workshop will in#PERMITprojectoject's work to establish recommendation#PersonalisedMedicineicine methods, sci.excellence, validity, robustness, & mpermit-eu.orgRIGbW https://t.co/EAIesHPuRn
🔚Thats a wrap! A fruitful day f#PERMITprojectect: 🧠Brainstorming the ethical issu#PersonalisedMedicinedicine with colleaguesECRIN_ERICN_ERIC & TMF-VE, and clinician, ethi#HTA, #HTA #patientatient representatives Learn more about PERMIT & the role of EPeu-patient.eu/Projects/ongoi…TfHNgM https://t.co/HqkyWgbZn8
Attention personalised medicine community and members of the #PERMITproject. The most recent member of the ICPerMed family is planning two information sessions (EN & FR) in December. Don't miss this opportunity to learn about how this project will develop new collaborations. twitter.com/EU_AfricaPerMe…